Autor: |
Yana O. Romanenko, Marina V. Silkina, Alena S. Kartseva, Maksim A. Marin, Maria A. Shkuratova, Maria A. Makarova, Alena K. Ryabko, Daria A. Konyshkova, Natalia A. Zeninskaya, Anna E. Khlyntseva, Igor G. Shemyakin, Victoria V. Firstova |
Rok vydání: |
2023 |
Předmět: |
|
Zdroj: |
Acta Naturae. 15:81-86 |
ISSN: |
2075-8243 |
Popis: |
The new coronavirus infection COVID-19 is an acute viral disease that affects primarily the upper respiratory tract. The etiological agent of COVID-19 is the SARS-CoV-2 RNA virus (Coronaviridae family, Betacoronavirus genus, Sarbecovirus subgenus). We have developed a high-affinity human monoclonal antibody, called C6D7-RBD, which is specific to the S protein receptor-binding domain (RBD) from the SARS-CoV-2 Wuhan-Hu-1 strain and exhibits virus-neutralizing activity in a test with recombinant antigens: angiotensin-converting enzyme 2 (ACE2) and RBD. |
Databáze: |
OpenAIRE |
Externí odkaz: |
|